Comparison

Dovitinib (TKI258) Lactate

Item no. DCC-DC3141-250mg
Manufacturer DCChemicals
CASRN 915769-50-5
Amount 250 mg
Quantity options 100 mg 1 g 250 mg
Category
Type Inhibitors
Specific against other
Purity 99%
Smiles O=C1NC2=C(C(F)=CC=C2)C(N)=C1C3=NC4=CC=C(N5CCN(C)CC5)C=C4N3.CC(O)C(O)=O.[H]O[H]
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias TKI258,CHIR258,Dovitinib (TKI 258,CHIR 258)
Similar products 915769-50-5
Available
Manufacturer - Applications
Dovitinib (TKI258, CHIR258) is a novel multi-target inhibitor for Flt3, c-Kit, FGFR1/3, VEGFR1/2/3, PDGFRα/β with IC50 of 1 nM, 2 nM, 8 nM/9 nM and 10 nM/13 nM/8 nM, 210 nM/27 nM respectively.
Storage Conditions
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Molecular Weight
500, 52266
Note
For research only, not for human use!

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 250 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close